 |
20 Diseases |  |
1 Trial |
|
1 Trial |  |
104 News |  |
| «12 |
- ||| zotiraciclib (TG02) / Cothera Biosci
New P1 trial: STEAM: Study of TG02 in Elderly Newly Diagnosed or Adult Relapsed Patients With Anaplastic Astrocytoma or Glioblastoma (clinicaltrials.gov) - Jul 21, 2017
P1, N=81, Not yet recruiting, Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
- zotiraciclib (TG02) / Cothera Biosci
Enrollment open: Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma (clinicaltrials.gov) - Dec 2, 2016
P2, N=152, Recruiting, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting
- | zotiraciclib (TG02) / Cothera Biosci
New P2 trial: Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma (clinicaltrials.gov) - Oct 25, 2016
P2, N=152, Not yet recruiting, Sponsor: National Cancer Institute (NCI)
- | TG02 / Circio Holding
New P1 trial, Monotherapy, PD(L)-1 Biomarker, IO biomarker, Metastases: Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Safety and Immune Activation in Patients With Locally Advanced Primary and Recurrent Oncogenic RAS Exon 2 Mutant Colorectal Cancer (clinicaltrials.gov) - Oct 17, 2016
P1, N=20, Recruiting, Sponsor: Targovax ASA
- | zotiraciclib (TG02) / Cothera Biosci
Trial completion, Trial primary completion date: Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (clinicaltrials.gov) - May 6, 2016
P1, N=30, Completed, Sponsor: Tragara Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Jul 2015
- ||| zotiraciclib (TG02) / Cothera Biosci
Metastases: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies (clinicaltrials.gov) - May 6, 2016
P1, N=120, Completed, Sponsor: Tragara Pharmaceuticals, Inc.
Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Jul 2015 Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Mar 2016
- || zotiraciclib (TG02) / Cothera Biosci
Metastases: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies (clinicaltrials.gov) - Nov 9, 2015
P1, N=120, Recruiting, Sponsor: Tragara Pharmaceuticals, Inc.
Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Mar 2016 Trial primary completion date: Mar 2016 --> Jun 2016
- zotiraciclib (TG02) / Cothera Biosci
Enrollment closed: Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (clinicaltrials.gov) - Sep 14, 2015
P1, N=30, Active, not recruiting, Sponsor: Tragara Pharmaceuticals, Inc.
Trial primary completion date: Mar 2016 --> Jun 2016 Recruiting --> Active, not recruiting
- zotiraciclib (TG02) / Cothera Biosci
Trial primary completion date: Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (clinicaltrials.gov) - Apr 14, 2015
P1, N=30, Recruiting, Sponsor: Tragara Pharmaceuticals, Inc.
Recruiting --> Active, not recruiting Trial primary completion date: Mar 2015 --> Mar 2016
- || zotiraciclib (TG02) / Cothera Biosci
Metastases: Phase 1 Study of TG02 Citrate in Patients With Advanced Hematological Malignancies (clinicaltrials.gov) - Apr 9, 2015
P1, N=120, Recruiting, Sponsor: Tragara Pharmaceuticals, Inc.
Trial primary completion date: Mar 2015 --> Mar 2016 N=100 --> 120 | Trial primary completion date: Apr 2015 --> Mar 2016
- zotiraciclib (TG02) / Cothera Biosci
Trial primary completion date: Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (clinicaltrials.gov) - Sep 5, 2014
P1, N=30, Recruiting, Sponsor: Tragara Pharmaceuticals, Inc.
N=100 --> 120 | Trial primary completion date: Apr 2015 --> Mar 2016 Trial primary completion date: Jul 2014 --> Mar 2015
- | zotiraciclib (TG02) / Cothera Biosci
New P1 trial: Phase 1 Study of TG02 Citrate in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (clinicaltrials.gov) - Oct 1, 2012
P1, N=30, Recruiting, Sponsor: Tragara Pharmaceuticals, Inc.